Publications by authors named "Jose D Posada"

Article Synopsis
  • The study aimed to evaluate the adoption of second-line antihyperglycaemic medications among type 2 diabetes patients using metformin, analyzing data from 10 US and 7 international health databases.
  • A total of 4.8 million participants were included, focusing on the trends in initiating additional diabetes treatments over the years 2011 to 2021.
  • Results showed significant growth in the use of cardioprotective drugs (like GLP-1 receptor agonists and SGLT2 inhibitors) as second-line options, with initiation rates varying widely across countries and databases.
View Article and Find Full Text PDF
Article Synopsis
  • Ranitidine, a commonly used medication for stomach issues, was recalled in 2020 due to the discovery of a cancer-causing impurity, raising concerns about its link to cancer among users.
  • This study aimed to investigate the cancer risk associated with ranitidine compared to other similar medications known as H2 receptor antagonists.
  • Conducted across multiple countries and databases with a large sample size, the research compared cancer incidence in new users of ranitidine against those using alternatives while accounting for various factors to ensure accurate results.
View Article and Find Full Text PDF

Objective: Development of electronic health records (EHR)-based machine learning models for pediatric inpatients is challenged by limited training data. Self-supervised learning using adult data may be a promising approach to creating robust pediatric prediction models. The primary objective was to determine whether a self-supervised model trained in adult inpatients was noninferior to logistic regression models trained in pediatric inpatients, for pediatric inpatient clinical prediction tasks.

View Article and Find Full Text PDF

Objective: To describe the infrastructure, tools, and services developed at Stanford Medicine to maintain its data science ecosystem and research patient data repository for clinical and translational research.

Materials And Methods: The data science ecosystem, dubbed the Stanford Data Science Resources (SDSR), includes infrastructure and tools to create, search, retrieve, and analyze patient data, as well as services for data deidentification, linkage, and processing to extract high-value information from healthcare IT systems. Data are made available via self-service and concierge access, on HIPAA compliant secure computing infrastructure supported by in-depth user training.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the incidence rates of adverse events of special interest (AESIs) following COVID-19 infection with historical rates in the general population, focusing on 16 specific health outcomes.
  • Researchers conducted a multinational cohort study using diverse health data from 2017 to 2022 and found that post-COVID-19 AESIs were consistently more common, with significant variations based on age and population demographics.
  • The findings indicated that thromboembolic events, like pulmonary embolism, were particularly prevalent after a COVID-19 infection, highlighting the need for further research on long-term complications related to the virus.
View Article and Find Full Text PDF
Article Synopsis
  • The study emphasizes the importance of real world data (RWD) for understanding and responding to the COVID-19 pandemic using a standardized approach through the CHARYBDIS framework.
  • Researchers conducted a retrospective database study across multiple countries, including the US and parts of Europe and Asia, involving over 4.5 million individuals and focusing on their clinical characteristics and outcomes.
  • Findings reveal higher diagnoses among women but more hospitalizations among men, common comorbidities like diabetes and heart disease, and key symptoms such as cough and fever; this data helps to identify trends in COVID-19 across different populations and time periods.
View Article and Find Full Text PDF

Objective: To characterise patients with and without prevalent hypertension and COVID-19 and to assess adverse outcomes in both inpatients and outpatients.

Design And Setting: This is a retrospective cohort study using 15 healthcare databases (primary and secondary electronic healthcare records, insurance and national claims data) from the USA, Europe and South Korea, standardised to the Observational Medical Outcomes Partnership common data model. Data were gathered from 1 March to 31 October 2020.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed the demographics, cancer types, comorbidities, and outcomes of patients with a history of cancer who contracted COVID-19, comparing them to those hospitalized with influenza.
  • A total of 366,050 diagnosed patients and 119,597 hospitalized patients with COVID-19 were included, with prostate and breast cancers being the most common among the diagnosed cohort, and many patients over 65 years old having multiple health issues.
  • The findings revealed a significant occurrence of COVID-19-related deaths among cancer patients, with a range of 2% to 26% depending on hospitalization status, highlighting the need for tailored clinical care for this high-risk group.
View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to compare the demographics, medical conditions, and outcomes of COVID-19 patients with obesity to those without obesity, based on data from Spain, the UK, and the US from early 2020.
  • - A total of over 600,000 diagnosed and over 160,000 hospitalized COVID-19 patients were analyzed, revealing a higher prevalence of obesity among hospitalized patients and noted that women were more frequently represented in the PLWO group.
  • - Results indicated that patients living with obesity (PLWO) had more prior medical conditions, experienced more severe COVID-19 symptoms, and required greater hospital resources compared to those without obesity, highlighting the need for tailored preventive measures.
View Article and Find Full Text PDF

Objectives: To characterize the demographics, comorbidities, symptoms, in-hospital treatments, and health outcomes among children and adolescents diagnosed or hospitalized with coronavirus disease 2019 (COVID-19) and to compare them in secondary analyses with patients diagnosed with previous seasonal influenza in 2017-2018.

Methods: International network cohort using real-world data from European primary care records (France, Germany, and Spain), South Korean claims and US claims, and hospital databases. We included children and adolescents diagnosed and/or hospitalized with COVID-19 at age <18 between January and June 2020.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore the use of repurposed and supporting drugs in COVID-19 patients hospitalized across the US, Spain, China, and South Korea during 2020.
  • A total of 303,264 hospital patients were analyzed, with significant variation in drug prescriptions between countries; hydroxychloroquine had a dramatic increase in use in Spain but was virtually unused in China.
  • Findings showed that alongside repurposed drugs, adjunct treatments like enoxaparin, fluoroquinolones, and corticosteroids were commonly administered, highlighting the need for further research on their effectiveness and safety.
View Article and Find Full Text PDF

Neuronal damage secondary to traumatic brain injury (TBI) is a rapidly evolving condition, which requires therapeutic decisions based on the timely identification of clinical deterioration. Changes in S100B biomarker levels are associated with TBI severity and patient outcome. The S100B quantification is often difficult since standard immunoassays are time-consuming, costly, and require extensive expertise.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the 30-day outcomes and mortality of patients with autoimmune diseases hospitalized due to COVID-19, comparing them to similar hospital patients with seasonal influenza.
  • Researchers analyzed data from multiple health institutions and found that most patients were older females with significant comorbidities.
  • Results indicated that COVID-19 led to more respiratory complications and higher mortality rates (up to 24.6%) compared to influenza (up to 4.3%).
View Article and Find Full Text PDF

Objective: To propose a paradigm for a scalable time-aware clinical data search, and to describe the design, implementation and use of a search engine realizing this paradigm.

Materials And Methods: The Advanced Cohort Engine (ACE) uses a temporal query language and in-memory datastore of patient objects to provide a fast, scalable, and expressive time-aware search. ACE accepts data in the Observational Medicine Outcomes Partnership Common Data Model, and is configurable to balance performance with compute cost.

View Article and Find Full Text PDF

Incident depression has been reported to be associated with poor prognosis in patients with cardiovascular disease (CVD), which might be associated with beta-blocker therapy. Because early detection and intervention can alleviate the severity of depression, we aimed to develop a machine learning (ML) model predicting the onset of major depressive disorder (MDD). A model based on 1 regularized logistic regression was trained against the South Korean nationwide administrative claims database to identify risk factors for the incident MDD after beta-blocker therapy in patients with CVD.

View Article and Find Full Text PDF
Article Synopsis
  • This study aimed to determine how many COVID-19 patients hospitalized in the U.S. needed procedures like dialysis, tracheostomy, and ECMO.
  • It analyzed data from 842,928 hospitalized COVID-19 patients, revealing that about 4.17% received dialysis, while less than 1% had tracheostomy or ECMO interventions.
  • Findings showed that ECMO was more frequently used in younger males with fewer health issues, while tracheostomy rates were similar across demographics, and dialysis was more common in males and those with chronic kidney disease.
View Article and Find Full Text PDF
Article Synopsis
  • A study investigated the 30-day outcomes and mortality of patients with autoimmune diseases hospitalized due to COVID-19, highlighting increased complications compared to those admitted for seasonal influenza.
  • The research used electronic health records from various healthcare institutions across the U.S. and Spain, analyzing data from over 133,000 COVID-19 patients and similar influenza patients.
  • Results showed that COVID-19 patients with autoimmune diseases experienced higher rates of respiratory issues and significantly increased 30-day mortality rates, indicating poorer outcomes compared to those with influenza.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the demographics, comorbidities, symptoms, treatments, and outcomes of children and adolescents diagnosed or hospitalized with COVID-19, comparing these to those diagnosed with seasonal influenza.
  • Utilizing real-world data from multiple countries including France, Germany, Spain, South Korea, and the US, the research included over 55,000 children with COVID-19 and nearly 2 million with influenza between specified periods.
  • Key findings indicate that comorbidities were more prevalent in hospitalized COVID-19 cases, fever was the most common symptom, and while hospitalization rates were low, complications like pneumonia and multi-system inflammatory syndrome were significantly more common in COVID-19 cases compared to influenza.
View Article and Find Full Text PDF
Article Synopsis
  • - Early identification of COVID-19 symptoms and related health conditions is crucial for managing the pandemic and improving healthcare responses, as shown by analysis of over 3 million tested individuals across various countries.
  • - The majority of COVID-positive participants were women aged 18-65, with symptoms like fever, cough, and difficulty breathing being the most common; hospitalization rates varied from 4% to 38%, with mortality rates ranging from 1% to 10.5% within a month of testing positive.
  • - Significant geographic and temporal differences in testing ratios and healthcare outcomes highlight the need for comprehensive international data analysis to better inform public health strategies and resource allocation, especially as countries prepare for potential future waves of the virus.
View Article and Find Full Text PDF
Article Synopsis
  • * A study analyzed 34,128 COVID-19 patients across the US, South Korea, and Spain, revealing differences in gender and age demographics among countries.
  • * Compared to influenza patients hospitalized from 2014-2019, COVID-19 patients tend to be younger, more often male, and have fewer comorbidities and lower medication use, indicating a need for tailored response strategies.
View Article and Find Full Text PDF

Background In this study we phenotyped individuals hospitalised with coronavirus disease 2019 (COVID-19) in depth, summarising entire medical histories, including medications, as captured in routinely collected data drawn from databases across three continents. We then compared individuals hospitalised with COVID-19 to those previously hospitalised with influenza. Methods We report demographics, previously recorded conditions and medication use of patients hospitalised with COVID-19 in the US (Columbia University Irving Medical Center [CUIMC], Premier Healthcare Database [PHD], UCHealth System Health Data Compass Database [UC HDC], and the Department of Veterans Affairs [VA OMOP]), in South Korea (Health Insurance Review & Assessment [HIRA]), and Spain (The Information System for Research in Primary Care [SIDIAP] and HM Hospitales [HM]).

View Article and Find Full Text PDF

In response to the challenges set forth by the CEGS N-GRID 2016 Shared Task in Clinical Natural Language Processing, we describe a framework to automatically classify initial psychiatric evaluation records to one of four positive valence system severities: absent, mild, moderate, or severe. We used a dataset provided by the event organizers to develop a framework comprised of natural language processing (NLP) modules and 3 predictive models (two decision tree models and one Bayesian network model) used in the competition. We also developed two additional predictive models for comparison purpose.

View Article and Find Full Text PDF